Presentation is loading. Please wait.

Presentation is loading. Please wait.

1 Life Technologies™ Proprietary | AIPLA Winter Meeting Presentation January 2013.

Similar presentations


Presentation on theme: "1 Life Technologies™ Proprietary | AIPLA Winter Meeting Presentation January 2013."— Presentation transcript:

1 1 Life Technologies™ Proprietary | AIPLA Winter Meeting Presentation January 2013

2 2 Life Technologies™ Proprietary | Life Technologies Today 1000s of products - Research & Applied Markets Consumables and instruments used to sequence and analyze DNA Consumables and instruments used to analyze gene functions Next generation sequencing Consumables for all types of sample preparation, gene expression and cellular research Cell culture media for drug development Molecular and cell biology reagents Endpoint PCR benchtop instruments and consumables BioProduction Forensic Testing Capillary Eletrophoresis and qPCR instruments Animal Health and Food Safety Medical Sciences Genetic Analysis Applied Sciences Research Consumables

3 3 Life Technologies™ Proprietary | Strong Competitive Advantages In All End Markets Broad product offerings Strong, most scientifically cited brands Comprehensive solutions Customizable e-Procurement offerings World-renowned media formulation for biotech Technology provider to diagnostic laboratories Established protocols in Forensics Growing number of offerings for AgBio, Food & Safety, Synthetic Genomics Academic / Government Pharma / Biotech Commercial Applications Hospital / Clinics

4 4 Life Technologies™ Proprietary | 2. Lead product innovation Offering a Full Range of Solutions for the Life Science Market CE Sequencing qPCR Best-in-class reagents and consumables Confirmation / Validation Sample prep and follow-on experiments Next Generation Sequencing Discovery

5 5 Life Technologies™ Proprietary | Launched Pervenio™ lung cancer test service in Q3 Northern California based genomics testing provider CLIA certified lab in all 50 states and physician/patient software infrastructure Building Our Diagnostics Franchise Positions LIFE as a partner of choice for drug and companion diagnostic development

6 6 Life Technologies™ Proprietary | Life Tech has a Large Patent Porfolio Broad and deep patent portfolio Over 4,000 owned or controlled patents Relevant to molecular diagnostics Underlying technologies Sample prep Genetic analysis Methods, reagents and instruments Specific molecular Dx assays [developing] Life Tech’s portfolio relates to underlying molecular Dx technologies


Download ppt "1 Life Technologies™ Proprietary | AIPLA Winter Meeting Presentation January 2013."

Similar presentations


Ads by Google